InsiderTrades

Form 4 for AORT ARTIVION, INC.

Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-07 · accession 0000784199-22-000016 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-08 2022-02-07 AORT Mackin James P Pres, CEO S - Sale+OE $17.30 -10.6K 304.2K -3% -$184.0K
D 2022-02-08 2022-02-07 AORT Mackin James P Pres, CEO M - OptEx $11.00 +10.6K 314.8K +3% +$117.0K
D 2022-02-08 2022-02-07 AORT Mackin James P Pres, CEO M - OptEx $11.00 -10.6K 31.9K -25% -$117.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-07 S D 10,638 $17.30 304,178 D — — (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 (F2) Reflects weighted average price. Range of prices were between $16.90 to $17.51. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2022-02-07 M A 10,638 $11.00 314,816 D — — (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021
3 Derivative StockOption(Right To Buy) 2022-02-07 M D 10,638 $11.00 31,915 D $11.00 · 2016-02-19 to 2022-02-19 10,638 Common Stock (F3) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016